Dermatology Consulting Services

High Point, North Carolina 27262

0 studies enrolling now · 54 studies all time

What they study most

ACTINIC KERATOSIS, Acne, Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Atopic Dermatitis, Cellulite, Chronic Pruritus, Edematous Fibrosclerotic Panniculopathy, Hair Thinning, Keloids, Moderate to Severe Acne Vulgaris

Studies at this site

• A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients — Completed
• Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men — Completed
• RCT of an Oral Acne Supplement for Adult Women — Completed
• An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis — Completed
• DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1% — Completed
• VPD-737 for Treatment of Chronic Pruritus — Completed
• A Study of S6G5T-3 in the Treatment of Acne Vulgaris — Completed
• A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis — Completed
• Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris — Completed
• Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Topical CP-690,550 For Chronic Plaque Psoriasis — Completed
• Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence — Stopped early
• Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris — Completed
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris — Completed
• A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis — Completed
• Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults — Completed
• An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis — Completed
• Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris — Completed
• Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) — Completed
• Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis — Completed
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis — Completed
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis — Completed
• The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea — Completed
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) — Completed
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early
• A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash — Completed
• A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp — Completed
• AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis — Completed
• Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne — Completed
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail. — Completed
• The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis — Completed
• A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 — Completed
• Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies — Completed
• Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis — Completed
• Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis — Stopped early
• Tofacitinib Ointment For Chronic Plaque Psoriasis — Completed
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients — Completed
• Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris — Completed
• Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis — Completed
• Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails — Stopped early
• Clinical Trial To Evaluate ANT-1207 In Subjects With Acne — Completed